Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Microbiology Spectrum|March 29, 2023
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected PatientsYu-Shan Huang, Chien-Yu Cheng, Hsin-Yun Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 10, 2022
Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19Wang-Da Liu, Jann-Tay Wang, Tai-Ling Chao, et al.
Journal of Arrhythmia|July 2, 2025
Long-term outcome of lesion size index-guided high-power ablation with high-density mapping for pulmonary vein isolation in patients with paroxysmal atrial fibrillationMing-Jen Kuo, Shih-Lin Chang, Jin-Long Huang, et al.
International Journal of Antimicrobial Agents|July 5, 2022
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimensGuan-Jhou Chen, Hsin-Yun Sun, Ling-Ya Chen, et al.
Plos One|July 1, 2017
Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-upKuan-Yin Lin, Chien-Yu Cheng, Chia-Wen Li, et al.
Journal of Cardiovascular Electrophysiology|May 15, 2025
Electrocardiographic Characteristics of Ventricular Arrhythmias Originating From High Right Ventricular Outflow Tract and Pulmonary ArteryMing-Jen Kuo, Chin-Yu Lin, Jin-Long Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 18, 2023
Factors associated with viral rebound among COVID-19 patients receiving oral antiviralsPao-Yu Chen, Jann-Tay Wang, Sui-Yuan Chang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 21, 2019
Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in TaiwanWang-Da Liu, Wan-Chen Tsai, Wei-Ting Hsu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2018
Less Severe but Prolonged Course of Acute Hepatitis A in Human Immunodeficiency Virus (HIV)-Infected Patients Compared With HIV-Uninfected Patients During an Outbreak: A Multicenter Observational StudyYu-Lin Lee, Guan-Jhou Chen, Nan-Yu Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|March 14, 2025
Measurements of tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots of people receiving pre-exposure prophylaxis for HIV with co-formulated tenofovir disoproxil fumarate and emtricitabineYa-Ting Lin, Wang-Da Liu, Chih-Ning Cheng, et al.
Pageof 19